Diagnostic utility of p16^INK4a: a reappraisal of its use in cervical biopsies

References

• Bosch F X, Lorincz A, Munoz N, et al. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 2002; 55: 244–265
   PubMed Web of Science ®Google Scholar
• Syrjanen K J. Immunohistochemistry in assessment of molecular pathogenesis of cervical carcinogenesis. Eur J Gynaecol Oncol 2005; 26: 5–18
   PubMed Web of Science ®Google Scholar
• Sherr C J, McCormick F. The Rb and p53 pathways in cancer. Cancer Cell 2002; 2: 103–112
   PubMed Web of Science ®Google Scholar
• Ishikawa F. Cellular senescence, an unpopular yet trustworthy tumor suppressor mechanism. Cancer Sci 2003; 94: 944–947
   PubMed Web of Science ®Google Scholar
• Narisawa-Saito M, Kiyono T. Basic mechanisms of high-risk human papillomavirus-induced carcinogenesis: roles of E6 and E7 proteins. Cancer Sci 2007; 98: 1505–1511
   PubMed Web of Science ®Google Scholar
• Papazoglu C, Mills A A. p53: at the crossroads between cancer and ageing. J Pathol 2007; 211: 124–133
   PubMed Web of Science ®Google Scholar
• Vermeulen K, Van Bockstaele D R, Berneman Z N. The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer. Cell Prolif 2003; 36: 131–149
   PubMed Web of Science ®Google Scholar
• von Knebel D M. New markers for cervical dysplasia to visualise the genomic chaos created by aberrant oncogenic papillomavirus infections. Eur J Cancer 2002; 38: 2229–2242
   PubMed Web of Science ®Google Scholar
• Keating J T, Cviko A, Riethdorf S, et al. Ki-67, cyclin E, and p16INK4a are complimentary surrogate biomarkers for human papilloma virus-related cervical neoplasia. Am J Surg Pathol 2001; 25: 884–891
   PubMed Web of Science ®Google Scholar
• Keating J T, Ince T, Crum C P. Surrogate biomarkers of HPV infection in cervical neoplasia screening and diagnosis. Adv Anat Pathol 2001; 8: 83–92
   PubMed Web of Science ®Google Scholar
• Sano T, Masuda N, Oyama T, et al. Overexpression of p16INK4a and p14ARF is associated with human papillomavirus infection in cervical squamous cell carcinoma and dysplasia. Pathol Int 2002; 52: 375–383
   PubMed Web of Science ®Google Scholar
• Agoff S N, Lin P, Morihara J, et al. p16INK4a expression correlates with degree of cervical neoplasia: A comparison with Ki-67 expression and detection of high-risk HPV types. Mod Pathol 2003; 16: 665–673
   PubMed Web of Science ®Google Scholar
• Negri G, Egarter-Vigl E, Kasal A, et al. p16INK4a is a useful marker for the diagnosis of adenocarcinoma of the cervix uteri and its precursors: an immunohistochemical study with immunocytochemical correlations. Am J Surg Pathol 2003; 27: 187–193
   PubMed Web of Science ®Google Scholar
• McCluggage W G. Immunohistochemistry as a diagnostic aid in cervical pathology. Pathology 2007; 39: 97–111
   PubMed Web of Science ®Google Scholar
• Riethdorf L, Riethdorf S, Lee K R, et al. Human papillomaviruses, expression of p16INK4a, and early endocervical glandular neoplasia. Hum Pathol 2002; 33: 899–904
   PubMed Web of Science ®Google Scholar
• Klaes R, Friedrich T, Spitkivsky D, et al. Over-expression of p16INK4a as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri. Int J Cancer 2001; 92: 276–284
   PubMed Web of Science ®Google Scholar
• O'Neill C J, McCluggage W G. p16INK4a expression in the female genital tract and its value in diagnosis. Adv Anat Pathol 2006; 13: 8–15
   PubMed Web of Science ®Google Scholar
• Wicha M S, Liu S, Dontu G. Cancer stem cells: An old idea – a paradigm shift. Cancer Res 2006; 66: 1883–1890
   PubMed Web of Science ®Google Scholar
• Mittal K. Utility of proliferation-associated marker MIB-1 in evaluating lesions of the uterine cervix. Adv Anat Pathol 1999; 6: 177–185
   PubMed Web of Science ®Google Scholar
• Martens J E, Arends J, Van der Linden P J, et al. Cytokeratin 17 and p63 are markers of the HPV target cell, the cervical stem cell. Anticancer Res 2004; 24: 771–776
   PubMed Web of Science ®Google Scholar
• Martens J E, Smedts F, van Muyden R C, et al. Reserve cells in human uterine cervical epithelium are derived from Mullerian epithelium at midgestational age. Int J Gynecol Pathol 2007; 26: 463–468
   PubMed Web of Science ®Google Scholar
• Bulkmans N W, Berkhof J, Bulk S, et al. High-risk HPV type-specific clearance rates in cervical screening. Br J Cancer 2007; 96: 1419–1424
   PubMed Web of Science ®Google Scholar
• Syrjanen K J. Spontaneous evolution of intraepithelial lesions according to the grade and type of the implicated human papilloma virus (HPV). Eur J Obstet Gynecol Reprod Biol 1996; 65: 45–53
   PubMed Web of Science ®Google Scholar
• Syrjanen K. Mechanisms and predictors of high-risk human papillomavirus (HPV) clearance in the uterine cervix. Eur J Gynaecol Oncol 2007; 28: 337–351
   PubMed Web of Science ®Google Scholar
• Balaton A J. Defining objectives for technical quality in immunohistochemistry. J Cell Pathol 1999; 4: 69–77
   Google Scholar
• Taylor C R. Standardization in immunohistochemistry: The role of antigen retrieval in molecular morphology. Biotech Histochem 2006; 81: 3–12
   PubMed Web of Science ®Google Scholar
• Sompuram S R. A molecular mechanism of formalin fixation and antigen retrieval. Am J Clin Pathol 2004; 121: 190–199
   PubMed Web of Science ®Google Scholar
• Leong AS-Y, Leong TY-M. Newer developments in immunohistology. J Clin Pathol 2006; 59: 1117–1126
   PubMed Web of Science ®Google Scholar
• Werner M, Chott A, Fabiano A, Battifora H. Effect of formalin fixation and processing on immunohistochemistry. Am J Surg Pathol 2000; 24: 1016–1019
   PubMed Web of Science ®Google Scholar
• Montero C. The antigen-antibody reaction in immunohistochemistry. J Histochem Cytochem 2003; 51: 1–4
   PubMed Web of Science ®Google Scholar
• Dapson R W. Macromolecular changes caused by formalin fixation and antigen retrieval. Biotech Histochem 2007; 82: 133–140
   PubMed Web of Science ®Google Scholar
• Yokoyama S, Kashima K, Inoue S, et al. Biotin-containing intranuclear inclusions in endometrial glands during gestation and puerperium. Am J Clin Pathol 1993; 99: 13–17
   PubMed Web of Science ®Google Scholar
• Sabattini E, Bisgaard K, Ascani S, et al. The EnVision++ system: A new immunohistochemical method for diagnostics and research. Critical comparison with the APAAP, ChemMate, CSA, LABC, and SABC techniques. J Clin Pathol 1998; 51: 506–511
   PubMed Web of Science ®Google Scholar
• Battifora H. Misuse of the term ‘expression’. Am J Clin Pathol 1989; 92: 708–709
   PubMed Web of Science ®Google Scholar
• Swanson P E. HIERanarchy: the state of the art in immunohistochemistry. Am J Clin Pathol 1997; 107: 139–140
   PubMed Web of Science ®Google Scholar
• Leong A SY. Quantitation in immunohistology: Fact or fiction. A discussion of variables that influence results. Appl Immunohistochem Mol Morphol 2004; 12: 1–13
   PubMedGoogle Scholar
• Klaes R, Benner A, Friedrich T, et al. p16INK4a immunohistochemistry improves interobserver agreement in the diagnosis of cervical intraepithelial neoplasia. Am J Surg Pathol 2002; 26: 1389–1399
   PubMed Web of Science ®Google Scholar
• Shi J, Liu H, Wilerson M, et al. Evaluation of p16INK4a, minichromosome maintenance protein 2, DNA topoisomerase IIα, and p16INK4a/ProExC in cervical squamous intraepithelial lesions. Hum Pathol 2007; 38: 1335–1344
   PubMed Web of Science ®Google Scholar
• Kalof A N, Evans M F, Simmons-Arnold L, et al. p16INK4a immunoexpression and HPV in situ hybridization signal patterns: potential markers of high-grade cervical intraepithelial neoplasia. Am J Surg Pathol 2005; 29: 674–679
   PubMed Web of Science ®Google Scholar
• Ichinose H. p16INK4a IHC in the diagnosis of cervical CIN. Am J Surg Pathol 2003; 27: 1284
   PubMed Web of Science ®Google Scholar
• Dray M, Russell P, Dalrymple C, et al. p16INK4a as a complementary marker of high-grade intraepithelial lesions of the uterine cervix. 1: Experience with squamous lesions in 189 consecutive cervical biopsies. Pathology 2005; 37: 112–124
   PubMed Web of Science ®Google Scholar
• Tringler B, Gup C J, Singh M, et al. Evaluation of p16INK4a and pRb expression in cervical squamous and glandular neoplasia. Hum Pathol 2004; 35: 689–696
   PubMed Web of Science ®Google Scholar
• Hariri J, Oster A. The negative predictive value of p16INK4a to assess the outcome of cervical intraepithelial neoplasia 1 in the uterine cervix. Int J Gynaecol Pathol 2007; 26: 223–228
   PubMed Web of Science ®Google Scholar
• Branca M, Ciotti M, Santini L, et al. p16INK4a expression is related to grade of CIN and high-risk human papillomavirus but does not predict virus clearance after conization or disease outcome. Int J Gynecol Pathol 2004; 23: 354–365
   PubMed Web of Science ®Google Scholar
• Burger R A, Monk B J, Kurosaki T, et al. Human papillomavirus trype 18: Association with poor prognosis in early stage cervical cancer. J Natl Cancer Inst 1996; 88: 1361–1368
   PubMedGoogle Scholar
• Bosch F X, Manos M M, Munoz N, et al. Prevalence of human papillomavirus in cervical cancer – a worldwide perspective. J Natl Cancer Inst 1995; 87: 796–802
   PubMed Web of Science ®Google Scholar
• Didelot-Rousseau M N, Nagot N, Costes-Martineau V, et al. Human papillomavirus genotype distribution and cervical squamous intraepithelial lesions among high-risk women with and without HIV-1 infection in Burkina Faso. Br J Cancer 2006; 95: 355–362
   PubMed Web of Science ®Google Scholar
• Masoudi H, Van Niekerk D J, Gilks C B, et al. Loss of p16INK4a expression in invasive squamous cell carcinoma of the uterine cervix is an adverse prognostic marker. Histopathology 2006; 49: 542–544
   PubMed Web of Science ®Google Scholar
• Goldstein N S, Hewitt S M, Taylor C R, et al. Recommendations for improved standardization of immunohistochemistry. Appl Immunohistochem Mol Morphol 2007; 15: 124–133
   PubMedGoogle Scholar
• Leong AS-Y. Pitfalls in diagnostic immunohistology. Adv Anat Pathol 2004; 11: 86–93
   PubMed Web of Science ®Google Scholar
• Ma L, Fisk J M, Zhang R R, et al. Eosinophilic dysplasia of the cervix. A newly recognized variant of cervical squamous intraepithelial neoplasia. Am J Surg Pathol 2004; 28: 1474–14784
   PubMed Web of Science ®Google Scholar
• Regauer S, Reich O. CK17 and p16INK4a expression patterns distinguish (atypical) immature squamous metaplasia from high-grade cervical intraepithelial neoplasia (CIN 111). Histopathology 2007; 50: 629–635
   PubMed Web of Science ®Google Scholar
• Duggan M A, Akbari M, Magliocco A M. Atypical immature cervical metaplasia: immunoprofiling and longitudinal outcome. Hum Pathol 2006; 37: 1473–1481
   PubMed Web of Science ®Google Scholar
• Miyatake T, Ueda Y, Yoshino K, et al. Clonality analysis and human papillomavirus infection in squamous metaplasia and atypical immature metaplasia of uterine cervix: Is atypical immature metaplasia a precursor to cervical intraepithelial neoplasia 3?. Int J Gynecol Pathol 2007; 26: 180–187
   PubMed Web of Science ®Google Scholar
• Andersson S, Rylander E, Larsson B, et al. The role of human papillomavirus in cervical adenocarcinoma carcinogenesis. Eur J Cancer 2001; 37: 246–250
   PubMed Web of Science ®Google Scholar
• Murphy N, Heffron C CBB, King B, et al. p16INK4a positivity in benign, premalignant and malignant cervical glandular lesions: A potential diagnostic problem. Virchows Arch 2004; 445: 610–615
   PubMed Web of Science ®Google Scholar
• Hashi A, Xu J Y, Kondo T, et al. p16INK4a overexpression independent of human papillomavirus infection in lobular endocervical glandular hyperplasia. Int J Gynecol Pathol 2006; 25: 187–194
   PubMed Web of Science ®Google Scholar
• Cameron R I, Maxwell P, Jenkins D, McCluggage W G. Immunohistochemical staining with MIB1, bcl2, p16 assists in the distinction of cervical glandular intraepithelial neoplasia from tubo-endometrial metaplasia, endometriosis and microglandular hyperplasia. Histopathology 2002; 41: 313–321
   PubMed Web of Science ®Google Scholar
• Milde-Langosch K, Riethdorf S, Kraus-Poppinghaus A, et al. Expression of cyclin-dependent kinase inhibitors p16INK4a MTS1, p21WAF1, and p27KIP1 in HPV-positive and HPV-negative cervical adenocarcinomas. Virchows Arch 2001; 439: 55–61
   PubMed Web of Science ®Google Scholar
• Xu J Y, Hashi A, Kondo T, et al. Absence of human papillomavirus infection in minimal deviation adenocarcinoma and lobular endocervical glandular hyperplasia. Int J Gynecol Pathol 2005; 24: 296–302
   PubMed Web of Science ®Google Scholar
• Melgoza F, Brewster W R, Wilczynski S, Rutgers J. p16INK4a-positive small cell neuroendocrine carcinoma of the endometrium. Int J Gynecol Pathol 2006; 25: 252–256
   PubMed Web of Science ®Google Scholar
• Mulvany N J, Allen D G. Combined large cell neuroendocrine and endometrioid carcinoma of the endometrium. Int J Gynecol Pathol 2007; 27: 49–57
   Web of Science ®Google Scholar
• McCluggage W G. Recent advances in immunohistochemistry in gynaecological pathology. Histopathology 2002; 40: 309–326
   PubMed Web of Science ®Google Scholar
• McCluggage W G. Immunohistochemical and functional biomarkers of value in female genital tract lesions. Int J Gynecol Pathol 2006; 25: 101–120
   PubMed Web of Science ®Google Scholar
• Ansari-Lari M A, Staebler A, Zaino R J, et al. Distinction of endocervical and endometrial adenocarcinomas. Immunohistochemical p16INK4a expression correlated with human papillomavirus (HPV) DNA detection. Am J Surg Pathol 2004; 28: 160–167
   PubMed Web of Science ®Google Scholar
• McCluggage W G, Jenkins D. p16INK4a immunoreactivity may assist in the distinction between endometrial and endocervical adenocarcinoma. Int J Gynecol Pathol 2003; 22: 231–235
   PubMed Web of Science ®Google Scholar
• Tambouret R, Bell D A, Young R H. Microcystic endocervical adenocarcinomas: a report of eight cases. Am J Surg Pathol 2000; 24: 369–374
   PubMed Web of Science ®Google Scholar
• Schlesinger C, Silverberg S G. Endocervical adenocarcinoma in situ of tubal type and its relation to atypical tubal metaplasia. Int J Gynecol Pathol 1999; 18: 1–4
   PubMed Web of Science ®Google Scholar
• Liang J, Mittal R K, Wei J J, et al. Utility of p16INK4a, CEA, Ki67, P53, ER/PR in the differential diagnosis of benign, premalignant, and malignant glandular lesions of the uterine cervix and their relationship with Silverberg scoring system for endocervical glandular lesions. Int J Gynecol Pathol 2006; 26: 71–75
   Web of Science ®Google Scholar
• Vang R, Vinh T N, Burks R T, et al. Pseudoinfiltrative tubal metaplasia of the endocervix; A potential form of in utero diethylstilbestrol exposure-related adenosis simulating minimal deviation adenocarcinoma. Int J Gynecol Pathol 2005; 24: 391–398
   PubMed Web of Science ®Google Scholar
• Nielsen G P, Stemmer-Rachaminov A O. Immunohistochemical survey of p16INK4a expression in normal human adult and infant tissues. Lab Invest 1999; 79: 1137–1141
   PubMed Web of Science ®Google Scholar
• O'Neill C J, McBride H A, Connolly L E, McCluggage W G. Uterine leiomyosarcomas are characterized by high p16, p53 and MIB1 expression in comparison with usual leiomyomas, leiomyoma variants and smooth muscle tumours of uncertain malignant potential. Histopathology 2007; 50: 851–858
   PubMed Web of Science ®Google Scholar
• Galmiche L, Coste-Burel M, Lopes P, et al. The expression of p16INK4a is not correlated with HPV status in CIN 1. Histopathology 2006; 48: 767
   PubMed Web of Science ®Google Scholar
• Wang H L, Lu D W. Detection of human papillomavirus DNA and expression of p16, Rb, and p53 proteins in small cell carcinomas of the uterine cervix. Am J Surg Pathol 2004; 28: 901–908
   PubMed Web of Science ®Google Scholar
• Semcjuk A, Boltze C, Marzee B, et al. p16INK4a alterations are accompanied by aberrant protein immunostaining in endometrial carcinomas. J Cancer Res Clin Oncol 2003; 129: 589–596
   PubMed Web of Science ®Google Scholar
• Hudelist G, Manavi M, Pischinger K I, et al. Physical state and expression of HPV DNA in benign and dysplastic cervical tissue: Different levels of viral integration are correlated with lesion grade. Gynecol Oncol 2004; 92: 873–880
   PubMed Web of Science ®Google Scholar
• Sathish N, Abraham P, Peecdicayil A, et al. Human papillomavirus 16 E6/E7 transcript and E2 gene status in patients with cervical neoplasia. Mol Diagn 2004; 8: 57–64
   PubMedGoogle Scholar
• Manavi M, Hudelist G, Fink-Retter A, et al. Human papillomavirus DNA integration and messenger RNA transcription in cervical low- and high-risk squamous intraepithelial lesions in Austrian women. Int J Gynecol Cancer 2007, Jun 22: Epub ahead of print
   PubMed Web of Science ®Google Scholar
• Lorincz A T, Reid R, Jenson A B, et al. Human papillomavirus infection of the cervix; relative risk association of 15 common anogenital types. Obstet Gynecol 1992; 79: 328–337
   PubMed Web of Science ®Google Scholar
• Hopman A H, Smedts F, Dignef W, et al. Transition of high-grade cervical intraepithelial neoplasia to microinvasive carcinoma is characterized by integration of HPV 16/18 and numerical chromosome abnormalities. J Pathol 2004; 202: 23–33
   PubMed Web of Science ®Google Scholar
• Duesberg P H. Are cancers dependent on oncogenes or on aneuploidy?. Cancer Genet Cytogenet 2003; 143: 89–91
   PubMedGoogle Scholar
• Stass S A, Mixson A J. Oncogenes and tumour suppressor genes: Therapeutic implications. Clin Cancer Res 1997; 3: 2687–2695
   PubMed Web of Science ®Google Scholar
• Burk R D, Terai M, Gravitt P E, et al. Distribution of human papillomavirus types 16 and 18 variants in squamous cell carcinomas and adenocarcinomas of the cervix. Cancer Res 2003; 63: 7215–7220
   PubMed Web of Science ®Google Scholar
• Zuna R E, Allen R A, Moore W E, et al. Distribution of HPV genotypes in 282 women with cervical lesions: Evidence for three categories of intraepithelial lesions based on morholoogy and HPV type. Mod Pathol 2007; 20: 167–174
   PubMed Web of Science ®Google Scholar
• Chen C A, Liu C Y, Chou H H, et al. The distribution and differential risks of human papillomavirus genotypes in cervical preinvasive lesions: A Taiwan copperative oncologic group study. Int J Gynecol Cancer 2006; 16: 1801–1808
   PubMed Web of Science ®Google Scholar
• Kovacic M B, Castle P E, Herrero R, et al. Relationships of human papillomavirus type, qualitative viral load, and age with cytologic abnormality. Cancer Res 2006; 66: 10112–10119
   PubMed Web of Science ®Google Scholar
• Im S S, Wilczynski S P, Burger R A, Bradley B J. Early stage cervical cancers containing human papillomavirus type 18 have more nodal metastasis and deeper stromal invasion. Clin Cancer Res 2003; 9: 4145–4150
   PubMed Web of Science ®Google Scholar
• Seidal T, Balaton A J, Battifora H. Interpretation and quantification of immunostains. Am J Surg Pathol 2001; 25: 1204–1207
   PubMed Web of Science ®Google Scholar
• Bast R C, Lilija H, Urban N, et al. Translational crossroads for biomarkers. Clin Cancer Res 2005; 11: 6103–6108
   PubMed Web of Science ®Google Scholar
• Lie A K, Risberg B, Borge B, et al. DNA- versus RNA-based methods for human papillomavirus detection in cervical neoplasia. Gynecol Oncol 2005; 97: 908–915
   PubMed Web of Science ®Google Scholar
• Lai H C, Sun C A, Yu M H, et al. Favourable clinical outcome of cervical cancers infected with human papilloma virus type 58 and related types. Int J Cancer 1999; 84: 553–557
   PubMed Web of Science ®Google Scholar
• Dalstein V, Riethmuller D, Pretet J L, et al. Persistence and load of high-risk HPV are predictors for development of high-grade cervical lesions: A longitudinal French cohort study. Int J Cancer 2003; 106: 396–403
   PubMed Web of Science ®Google Scholar
• Syrjanen K J. HPV infections in benign and malignant sinonasal lesions. J Clin Pathol 2003; 56: 174–181
   PubMed Web of Science ®Google Scholar
• Kong C S, Welton M L, Longacre T A. Role of human papillomavirus in squamous cell metaplasia-dysplasia-carcinoma of the rectum. Am J Surg Pathol 2007; 31: 919–925
   PubMed Web of Science ®Google Scholar
• Yao P F, Li G C, Li J, et al. Evidence of human papillomavirus infection and its epidemiology in esophageal squamous cell carcinoma. World J Gastroenterol 2006; 12: 1352–1355
   PubMed Web of Science ®Google Scholar